Listed by the USPTO as JARRELL, NOBLE E
Tech Center 1600 • Art Units: 1612 1621 1622 1624 1625 1629 1699
This examiner grants 81% of resolved cases
JARRELL, NOBLE E is assigned to tech center 1600 and art unit 1612. The profile records 1054 resolved cases, an 80.9% allowance rate, and a median of 1085 days to allowance. The 10.0% interview lift indicates a more limited interview-associated change than the overall allowance figure, while still providing a separate prosecution signal. Applicants can use the record to assess likely examination duration and the value of direct examiner discussion.
The listed companies are Boehringer Ingelheim International GmbH, Fujifilm Corporation, and Massachusetts Institute of Technology. The leading firms are MARSHALL, GERSTEIN & BORUN LLP, Baker, Donelson, Bearman, Caldwell & Berkowitz, PC, and BALLARD SPAHR LLP. Their histories may assist with research into biotechnology and pharmaceutical claim strategies in art unit 1612.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18091139 | CURABLE RESIN COMPOSITION, CURED PRODUCT, DIFFRACTIVE OPTICAL ELEMENT, AND MULTILAYER DIFFRACTIVE OPTICAL ELEMENT | Final Rejection | FUJIFILM Corporation |
| 18554231 | ANTICANCER THERAPY | Non-Final OA | Boehringer Ingelheim International GmbH |
| 17629303 | CYSTEINE BINDING COMPOSITIONS AND METHODS OF USE THEREOF | Non-Final OA | University of Virginia Patent Foundation |
| 18692541 | DIROXIMEL FUMARATE PARTICLES HAVING IMPROVED FLOW PROPERTIES AND METHODS OF MAKING SAME | Non-Final OA | BIOGEN MA INC. |
| 18000956 | POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL AND PHOTOCHROMIC LENS | Final Rejection | MITSUI CHEMICALS, INC. |
| 18543421 | COMBINATION THERAPIES | Non-Final OA | Mirati Therapeutics, Inc. |
| 18877765 | COMPOSITIONS AND METHODS FOR TREATING HEARING AND OCULAR DISORDERS | Non-Final OA | Anida Pharma Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy80.9% of resolved applications examined by Noble E Jarrell were allowed (1,054 resolved cases), compared with 40.7% across Art Unit 1612 over the last five years.
This examiner's interview lift is +10.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Noble E Jarrell took 1,085 days on average from filing to allowance.
Noble E Jarrell examines applications in Art Unit 1612 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
